Sicagen India (SICAGEN)₹56.66−0.44%Trading & Distributors
In the Jun 2026 quarter (consolidated), Sicagen India reported sales of ₹287 Cr, up 39.8% from Jun 2025, and net profit of ₹6.91 Cr, up 52.9% year on year. For the year to Mar 2026, sales were ₹977 Cr and net profit ₹17.95 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 181 | 229 | 222 | 233 | 199 | 211 | 253 | 206 | 228 | 265 | 279 | 287 |
| Expenses | 175 | 223 | 213 | 223 | 190 | 203 | 241 | 195 | 218 | 255 | 267 | 274 |
| Operating Profit | 5.10 | 5.21 | 8.37 | 9.26 | 8.26 | 6.89 | 10.62 | 9.75 | 9.07 | 9.26 | 11.22 | 12.42 |
| OPM % | 2.8% | 2.3% | 3.8% | 4.0% | 4.2% | 3.3% | 4.2% | 4.7% | 4.0% | 3.5% | 4.0% | 4.3% |
| Other Income | 1.48 | 2.84 | 1.45 | 2.02 | 2.71 | 3.51 | 2.39 | 1.91 | 1.74 | 2.68 | 3.10 | 2.02 |
| Interest | 2.46 | 2.64 | 2.93 | 2.61 | 2.82 | 2.49 | 3.06 | 3.03 | 2.70 | 2.67 | 4.28 | 2.75 |
| Depreciation | 2.13 | 2.20 | 3.34 | 2.30 | 2.32 | 2.40 | 3.52 | 2.40 | 2.38 | 2.38 | 3.68 | 2.40 |
| Profit before tax | 2.02 | 3.24 | 3.56 | 6.41 | 5.86 | 5.52 | 6.45 | 6.24 | 5.74 | 6.93 | 6.40 | 9.32 |
| Tax % | 35.3% | 28.2% | 12.6% | 24.9% | 29.2% | 23.8% | 38.2% | 27.1% | 27.7% | 28.6% | 30.0% | 25.4% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 1.29 | 2.31 | 3.09 | 4.79 | 4.13 | 4.18 | 3.96 | 4.52 | 4.13 | 4.92 | 4.45 | 6.91 |
| EPS (Rs) | 0.34 | 0.60 | 0.79 | 1.22 | 1.06 | 1.07 | 1.01 | 1.16 | 1.06 | 1.26 | 1.14 | 1.76 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 603 | 714 | 741 | 823 | 702 | 544 | 839 | 898 | 798 | 896 | 977 | 1,060 |
| Expenses | 609 | 707 | 738 | 818 | 689 | 533 | 815 | 870 | 768 | 856 | 935 | 1,014 |
| Operating Profit | −6.99 | 3.01 | 1.01 | 3.01 | 10.99 | 9.01 | 21.99 | 27.01 | 27.98 | 36.02 | 38.99 | 41.97 |
| OPM % | −1.2% | 0.5% | 0.1% | 0.4% | 1.6% | 1.6% | 2.7% | 3.0% | 3.5% | 4.1% | 4.0% | 4.0% |
| Other Income | 17.99 | 14.98 | 14.98 | 14.98 | 10.99 | 7.99 | 0.00 | 14.98 | 7.01 | 8.99 | 8.99 | 9.54 |
| Interest | 5.99 | 6.98 | 8.98 | 8.97 | 8.98 | 4.99 | 5.99 | 8.98 | 10.98 | 10.97 | 12.97 | 12.40 |
| Depreciation | 5.01 | 4.01 | 5.01 | 6.01 | 10.01 | 10.02 | 11.01 | 11.01 | 10.01 | 10.01 | 11.02 | 10.84 |
| Profit before tax | −1.01 | 8.02 | 2.01 | 3.01 | 3.01 | 1.01 | 5.01 | 22.05 | 14.03 | 24.08 | 25.08 | 28.39 |
| Tax % | −300.1% | 3.0% | 30.0% | 95.0% | 89.0% | 322.0% | 112.0% | 17.9% | 23.9% | 29.0% | 27.9% | — |
| Exceptional items | −0.10 | −0.16 | 0.00 | 0.09 | 0.00 | 0.58 | 0.80 | 6.11 | −0.40 | 1.03 | −0.23 | 0.00 |
| Net Profit | 0.99 | 6.98 | 0.99 | 0.00 | 0.00 | −2.99 | −0.99 | 17.95 | 10.97 | 16.96 | 17.95 | 20.41 |
| EPS (Rs) | 0.28 | 1.90 | 0.30 | 0.04 | 0.10 | −0.82 | −0.16 | 4.51 | 2.67 | 4.33 | 4.58 | 5.22 |
| Dividend payout % | 224.0% | 32.0% | 206.0% | 1,218.0% | 550.0% | −74.0% | −162.0% | 13.0% | 23.0% | 23.0% | 22.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 40.09 | 40.14 | 40.12 | 40.12 | 40.14 | 40.14 | 40.16 | 40.11 | 40.13 | 40.09 | 40.12 | 40.14 |
| Reserves | 439 | 443 | 345 | 353 | 343 | 336 | 355 | 383 | 400 | 420 | 444 | 455 |
| Borrowings | 47.90 | 59.84 | 88.80 | 96.99 | 119 | 95.75 | 78.97 | 94.76 | 121 | 121 | 148 | 159 |
| Other Liabilities | 83.93 | 76.10 | 105 | 115 | 184 | 133 | 72.34 | 140 | 68.18 | 143 | 90.36 | 86.41 |
| Total Liabilities | 610 | 619 | 578 | 605 | 685 | 605 | 547 | 657 | 629 | 723 | 722 | 741 |
| Fixed Assets | 59.21 | 57.22 | 184 | 204 | 152 | 169 | 169 | 142 | 141 | 141 | 137 | 141 |
| CWIP | 0.99 | 1.99 | 11.96 | 0.00 | 0.00 | 0.99 | 0.00 | 0.00 | 0.00 | 0.99 | 0.00 | 0.00 |
| Investments | 99.88 | 99.89 | 53.99 | 33.99 | 25.97 | 19.98 | 36.97 | 69.97 | 68.99 | 72.92 | 78.96 | 65.93 |
| Other Assets | 451 | 460 | 329 | 367 | 507 | 417 | 340 | 445 | 418 | 510 | 505 | 533 |
| Inventories | 88.31 | 87.30 | 120 | 123 | 116 | 134 | 105 | 104 | 145 | 132 | 130 | 149 |
| Trade receivables | 108 | 117 | 147 | 185 | 267 | 206 | 171 | 246 | 187 | 249 | 229 | 244 |
| Cash & equivalents | 22.01 | 31.96 | 23.97 | 16.01 | 73.95 | 16.99 | 34.96 | 27.99 | 28.99 | 45.94 | 68.01 | 84.95 |
| Total Assets | 610 | 619 | 578 | 605 | 685 | 605 | 547 | 657 | 629 | 723 | 722 | 741 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 1.99 | −2.99 | −40.92 | −11.97 | 19.96 | −36.91 | 30.96 | −1.99 | 14.97 | 24.94 | 32.92 | 43.92 |
| Cash from investing activity | 2.01 | 9.02 | 5.01 | 11.02 | −5.01 | 45.12 | −17.05 | 18.05 | −4.01 | −3.01 | −14.03 | −7.02 |
| Cash from financing activity | −10.99 | 3.99 | 21.95 | −3.99 | −11.99 | −17.97 | −11.99 | −17.98 | −12.99 | −19.97 | −16.99 | −18.98 |
| Net cash flow | −5.99 | 9.98 | −12.98 | −4.99 | 2.99 | −9.99 | 2.99 | −1.99 | −2.99 | 1.99 | 1.99 | 17.97 |
| Capex | 5.25 | 4.75 | 22.88 | 13.24 | 3.80 | 5.21 | 2.04 | 1.37 | 5.25 | 4.19 | 3.79 | 6.34 |
| Free cash flow | 4.01 | −8.01 | −64.10 | −25.04 | 63.05 | −42.06 | 29.03 | 13.02 | 11.01 | 22.03 | 33.05 | 38.06 |
| CFO / OP % | 325.9% | 43.0% | −1,191.0% | −1,130.1% | 832.0% | −312.0% | 377.9% | 16.0% | 65.0% | 99.0% | 103.0% | 123.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 61 | 71 | 75 | 91 | 119 | 108 | 115 | 107 | 76 | 114 | 94 | 91 |
| Inventory days | 55 | 58 | 69 | 67 | 57 | 77 | 79 | 49 | 64 | 66 | 59 | 62 |
| Days payable | 20 | 20 | 33 | 43 | 76 | 61 | 41 | 61 | 25 | 48 | 21 | 25 |
| Cash conversion cycle | 98 | 110 | 113 | 117 | 102 | 126 | 155 | 97 | 117 | 134 | 134 | 130 |
| Working capital days | 68 | 77 | 66 | 72 | 60 | 98 | 113 | 83 | 84 | 96 | 86 | 82 |
| ROCE % | 2.0% | 1.0% | 3.0% | 2.0% | 3.0% | 3.0% | 2.0% | 4.0% | 4.0% | 4.0% | 6.0% | 6.0% |
For the Jun 2026 quarter, Sicagen India reported sales of ₹287 Cr, up 39.8% year on year and net profit of ₹6.91 Cr, up 52.9% year on year. The operating margin was 4.3%.
Sicagen India's sales for the year to Mar 2026 were ₹977 Cr; over the last twelve months they were ₹1,060 Cr.
Net profit for the year to Mar 2026 was ₹17.95 Cr, and ₹20.41 Cr over the last twelve months. Earnings per share over the same trailing period were ₹5.22.
Sicagen India reported borrowings of ₹159 Cr at Mar 2026, against cash and equivalents of ₹84.95 Cr.
Cash from operations was ₹43.92 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹38.06 Cr.